MIR4638: A Potential Drug Target and Biomarker (G100616342)
MIR4638: A Potential Drug Target and Biomarker
MIR4638 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the hematopoietic stem cell (HSC) proliferation and has been shown to play a role in the development and maintenance of various diseases, including cancer.
MIR4638 is a small non-coding RNA molecule that contains 239 amino acid residues. It is expressed in various tissues, including the brain, heart, and gastrointestinal tract, and has been shown to play a role in the regulation of stem cell proliferation and differentiation.
One of the most promising aspects of MIR4638 is its potential as a drug target. MIR4638 has been shown to be involved in the regulation of several cellular processes, including cell growth, apoptosis, and inflammation. It has also been shown to interact with several protein molecules, including the transcription factor NF-kappa-B and the chemokine receptor PD-L1.
MIR4638 has also been shown to be a potential biomarker for several diseases, including cancer. It has been shown to be expressed in various types of cancer, including breast, ovarian, and colorectal cancer. Additionally, MIR4638 has been shown to be involved in the regulation of cancer cell migration and invasion, which are important steps in the development of cancer.
One of the challenges in studying MIR4638 is its relatively small size and the lack of information about its function in certain processes. However, research into MIR4638 is ongoing and it is expected to provide new insights into the regulation of stem cell proliferation and the development of various diseases.
In conclusion, MIR4638 is a promising drug target and biomarker that has the potential to be used to treat a variety of diseases. Further research is needed to fully understand its function and to develop safe and effective drugs that target MIR4638.
Protein Name: MicroRNA 4638
The "MIR4638 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4638 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4639 | MIR4640 | MIR4641 | MIR4642 | MIR4644 | MIR4645 | MIR4646 | MIR4647 | MIR4648 | MIR4649 | MIR4650-1 | MIR4650-2 | MIR4651 | MIR4652 | MIR4653 | MIR4655 | MIR4656 | MIR4657 | MIR4658 | MIR4659A | MIR4659B | MIR466 | MIR4660 | MIR4661 | MIR4662A | MIR4663 | MIR4664 | MIR4665 | MIR4666A | MIR4666B | MIR4667 | MIR4668 | MIR4669 | MIR4670 | MIR4671 | MIR4672 | MIR4673 | MIR4674 | MIR4675 | MIR4676 | MIR4677 | MIR4679-1 | MIR4679-2 | MIR4680 | MIR4681 | MIR4684 | MIR4685 | MIR4686 | MIR4687 | MIR4688 | MIR4689 | MIR4690 | MIR4691 | MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723 | MIR4724 | MIR4725 | MIR4726 | MIR4727 | MIR4728 | MIR4729 | MIR4730 | MIR4731 | MIR4732 | MIR4733 | MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741
